Popular literature | Zhongnan Medical Journal Press

Home Literature Popular literature

Popular literature

A comparative study of the clinical efficacy of moxifloxacin and azithromycin in the treatment of Mycoplasmal pneumoniae pneumonia

Published on Chinese Journal of Pharmacoepidemiology 2025,34(5):494-499.
6323 times 1682 times

ZHANG Kang LI Zhiming GE Yao

Moxifloxacin Azithromycin Mycoplasmal pneumoniae pneumonia Efficacy
Details
One case of anaphylaxis due to recurrent cervical cancer treated with candonilimab

Published on Chinese Journal of Pharmacoepidemiology 2025,34(5):600-604.
5990 times 2031 times

ZHANG Xiali MI Li LI Jingchao

Candonilimab Recurrent cervical cancer Anaphylaxis Adverse drug reactions
Details
Exploration on medication pattern of traditional Chinese medicine treatment for non-small cell lung cancer based on real world data

Published on Chinese Journal of Pharmacoepidemiology 2025,34(4):398-409.
5962 times 2209 times

LI Junya SHI Yanglin YANG Jianya LI Ya LI Suyun

Non-small cell lung cancer Traditional Chinese medicine Real-word data Latent structure model Association rule Medication pattern
Details
Analysis of the correlation between glucocorticoids and prognosis of severe viral pneumonia patients

Published on Chinese Journal of Pharmacoepidemiology 2025,34(5):524-531.
5768 times 2047 times

WU Xiayang HONG Suru CHEN Yushuang SU Yanqing

Glucocorticoids Severe viral pneumonia Prognosis Survival analysis MIMIC-Ⅳ database
Details
Guide on Methodological Standards in Pharmacoepidemiology in China (2nd edition) and their series interpretation (5): classic study designs and derivative approaches

Published on Chinese Journal of Pharmacoepidemiology 2025,34(5):485-493.
5643 times 2011 times

ZHANG Yiying YIN Shiwenqian MENG Shuhan WANG Shanjie ZHAN Siyan SUN Feng

Pharmacoepidemiology Methodology Guidelines Classic research type Derivative design
Details
Signal mining and analysis of adverse events of basiliximab used in solid organ transplantation based on FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2025,34(5):515-523.
5508 times 2200 times

CHENG Saisai ZHU Feng ZHOU Bi

Basiliximab Solid organ transplantation Adverse drug event FAERS database Data mining
Details
Clinical characteristics and drug resistance analysis of 408 patients with Escherichia coli bloodstream infection

Published on Chinese Journal of Pharmacoepidemiology 2025,34(5):507-514.
5458 times 2110 times

HU Peng CAI Tongjian WANG Yi CHENG Yao LIU Qiuqian XIAO Hong

Bloodstream infection Escherichia coli Extended-spectrum β-lactamases Clinical features Drug resistance
Details
Evidence map analysis of Chinese medicine treatment of premature ovarian insufficiency

Published on Chinese Journal of Pharmacoepidemiology 2025,34(5):556-566.
5430 times 1962 times

CHEN Kan WAN Li WANG Fang LIU Yingxue TANG Jinyan HAN Lu

Traditional Chinese medicine Premature ovarian insufficiency Meta-analysis Evidence map Overview of systematic review
Details
The research progress of siRNA drugs in obesity

Published on Chinese Journal of Pharmacoepidemiology 2025,34(5):589-594.
5403 times 2063 times

JIANG Fengxuan LU Qingmiao LU Yibing

siRNA drugs Obesity Weight loss Delivery system
Details
Effect of flurbiprofen axetil on postoperative catheter-related bladder discomfort: a randomized, controlled, double-blind trial

Published on Chinese Journal of Pharmacoepidemiology 2025,34(4):373-379.
5327 times 2117 times

LIU Zhidan SONG Bo LI Liping GUO Yinhao HE Hongxia XU Suihan ZHANG Yonghong LI Jun

Flurbiprofen axetil Transurethral resection of the prostate Catheter-related bladder discomfort Randomized controlled trial
Details
Study on the correlation between vancomycin therapeutic drug monitoring and short-term and long-term prognosis in sepsis patients based on the MIMIC-IV database

Published on Chinese Journal of Pharmacoepidemiology 2025,34(5):500-506.
5322 times 2021 times

WANG Yuan YANG Haiying CHEN Dan HUANG Na

Vancomycin Therapeutic drug monitoring Sepsis Prognosis Propensity score matched MIMIC-IV database
Details
Pharmaceutical care of a child with high-risk neuroblastoma using naxitamab

Published on Chinese Journal of Pharmacoepidemiology 2025,34(5):595-599.
5209 times 1953 times

CHEN Yin LIU Xin YU Liting ZHANG Min

Neuroblastoma Naxitamab Adverse drug reaction Pharmaceutical care Pain
Details
Research progress on the role of vitamin D and its signaling pathway in disease development

Published on Chinese Journal of Pharmacoepidemiology 2025,34(4):456-466.
4703 times 2542 times

ZHANG Xiaomei YE Hui YANG Fang MIN Rui TONG Yeqing

Vitamin D Signaling pathways Occurrence of disease
Details
Study on the effect of fumigation decoction on the expression of aggrecan and type II collagen in a rat model of intervertebral disc degeneration

Published on Chinese Journal of Pharmacoepidemiology 2025,34(5):548-555.
4516 times 2164 times

XIONG Guang DONG Chenpeng YANG Guoyu XU Zhiqiang WU Xinghuo

Fumigation decoction Fumigation Intervertebral disc degeneration Aggrecan Type II collagen Lumbar degenerative diseases
Details
Effect of butylphthalide on the risk of post-stroke epilepsy in patients with cerebral infarction

Published on Chinese Journal of Pharmacoepidemiology 2025,34(5):532-538.
4504 times 2091 times

YU Qi YUAN Junfeng CHEN Kai LI Xiuyun LI Zhanyong

Butylphthalide Cerebral infarction Post-stroke epilepsy
Details
Evaluation of off-label use of flupentixol melitracen based on evidence-based medicine

Published on Chinese Journal of Pharmacoepidemiology 2025,34(5):539-547.
4327 times 2289 times

WANG Chuanquan CAO Di ZHANG Shiyang

Flupentixol melitracen Evidence-based medicine Gastritis Vertigo Off-label drug use
Details
Efficacy and safety of azithromycin versus amoxicillin and clavulanate potassium in the treatment of children with otitis media: a systematic review and Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(5):567-577.
4234 times 1823 times

JIAN Jiejun LI Ni CHEN Zhe YU Zizhong

Azithromycin Amoxicillin and clavulanate potassium Otitis media Meta-analysis Systematic review Randomized controlled trial
Details
Application progress of novel targeted drugs in precision treatment of membranous nephropathy

Published on Chinese Journal of Pharmacoepidemiology 2025,34(4):467-473.
3978 times 1939 times

CHEN Wei LI Xiaowei

Membranous nephropathy Refractory membranous nephropathy Targeted therapy Anti-CD20 monoclonal antibodies Anti-B-cell activating factor monoclonal antibodies Anti-CD38 monoclonal antibodies Proteasome inhibitors Complement inhibitors Individualized treatment
Details
Pharmaceutical practice of a clinical pharmacist in the treatment of a patient with ulcerative colitis recurrence complicated by autoimmune pancreatitis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(4):474-479.
3956 times 1882 times

LUO Guangwen LI Dongyan

Ulcerative colitis Autoimmune pancreatitis Clostridium difficile infection Pharmaceutical monitoring
Details
A case report of immune-related multisystem adverse reactions caused by tislelizumab

Published on Chinese Journal of Pharmacoepidemiology 2025,34(3):359-364.
3889 times 536 times

SONG Qiuyan TAI Qirui ZHANG Bikui LUO Zhiying SUN Bao LIU Wenhui

Tislelizumab Myasthenia gravis Myositis Myocarditis Liver function damage Immune-related adverse reaction
Details